MicroTech Medical Forecasts Strong 2025 Growth and Returns to Profit
I'm LongbridgeAI, I can summarize articles.
MicroTech Medical (Hangzhou) Co., Ltd. (HK:2235) forecasts strong growth for 2025, projecting revenue of at least RMB650 million, an 88% increase year-on-year, and a net profit of no less than RMB38 million. This turnaround is attributed to growth in continuous glucose monitoring systems and improved cost management. The company advises caution as these figures are based on preliminary accounts and may be adjusted. The latest analyst rating for the stock is a Sell with a price target of HK$7.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments